| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 36.91B | 30.41B | 35.48B | 36.95B | 35.24B | 31.10B |
| Gross Profit | 23.95B | 18.15B | 21.73B | 23.01B | 22.82B | 20.07B |
| EBITDA | -641.00M | 748.00M | 2.31B | -76.00M | -1.11B | 2.90B |
| Net Income | -1.89B | -1.51B | 530.00M | -1.47B | -2.17B | 748.00M |
Balance Sheet | ||||||
| Total Assets | 22.13B | 14.52B | 19.05B | 20.42B | 22.66B | 24.43B |
| Cash, Cash Equivalents and Short-Term Investments | 5.08B | 3.63B | 6.70B | 4.66B | 5.57B | 7.07B |
| Total Debt | 6.30B | 5.65B | 5.38B | 6.24B | 6.24B | 6.94B |
| Total Liabilities | 15.08B | 10.84B | 11.74B | 13.66B | 14.44B | 14.04B |
| Stockholders Equity | 7.05B | 3.68B | 7.30B | 6.76B | 8.22B | 10.38B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.14B | -1.56B | -1.01B | -1.29B | 1.38B |
| Operating Cash Flow | 0.00 | -459.00M | -782.00M | 944.00M | 1.19B | 1.53B |
| Investing Cash Flow | 0.00 | -501.00M | 3.75B | -1.86B | -1.74B | 884.00M |
| Financing Cash Flow | 0.00 | -2.11B | -914.00M | 1.00M | -949.00M | -666.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥136.94B | 19.06 | ― | 1.88% | 21.61% | 11.23% | |
63 Neutral | ¥116.55B | 28.53 | ― | 0.70% | 6.85% | 45.60% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥652.36B | 35.05 | 9.53% | 0.55% | 12.02% | 20.18% | |
61 Neutral | ¥210.36B | 37.97 | ― | 0.69% | 10.09% | 22.64% | |
56 Neutral | ¥1.26T | 31.37 | 15.36% | 0.78% | 11.21% | 9.99% | |
47 Neutral | ¥129.18B | -78.18 | ― | ― | -14.29% | -384.36% |